Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 18.93%125.81M | 18.09%219.56M | 4.76%105.79M | 35.47%185.93M | 48.60%100.98M | 20.73%137.25M | 41.68%67.95M | 314.25%113.68M | 157.63%47.96M | -137.88%-53.06M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -15.52%-6.78M | -6.57%-12.67M | -85.90%-5.87M | -82.03%-11.89M | -109.08%-3.16M | -55.04%-6.53M | -482.63%-1.51M | -240.58%-4.21M | 66.54%-259K | 50.76%-1.24M |
| Impairment and provisions: | 642.98%657K | -99.91%15K | -402.50%-121K | 171.30%16.16M | -96.41%40K | 270.37%5.96M | 129.72%1.12M | -136.45%-3.5M | -396.13%-3.75M | 109.04%9.6M |
| -Impairment of trade receivables (reversal) | 642.98%657K | -99.91%15K | -402.50%-121K | 171.30%16.16M | -96.41%40K | 270.37%5.96M | 129.72%1.12M | -136.45%-3.5M | -396.13%-3.75M | 109.04%9.6M |
| Revaluation surplus: | -26.31%-2.61M | -10.35%-5.31M | 63.37%-2.06M | -16.94%-4.81M | -75.82%-5.64M | -18.08%-4.12M | 8.45%-3.21M | -31.61%-3.49M | -607.27%-3.5M | 20.60%-2.65M |
| -Other fair value changes | -26.31%-2.61M | -10.35%-5.31M | 63.37%-2.06M | -16.94%-4.81M | -75.82%-5.64M | -18.08%-4.12M | 8.45%-3.21M | -31.61%-3.49M | -607.27%-3.5M | 20.60%-2.65M |
| Asset sale loss (gain): | 107.55%110K | 2,951.72%1.77M | 112.00%53K | 728.57%58K | 257.14%25K | -99.77%7K | -99.77%7K | -45.20%3.06M | --3.06M | 1,565.67%5.58M |
| -Loss (gain) on sale of property, machinery and equipment | 107.55%110K | 2,951.72%1.77M | 112.00%53K | 728.57%58K | 257.14%25K | -99.77%7K | -99.77%7K | -45.20%3.06M | --3.06M | 1,565.67%5.58M |
| Depreciation and amortization: | -4.04%17.78M | -7.50%35.99M | -6.96%18.53M | 20.00%38.9M | 35.01%19.91M | 4.34%32.42M | -11.94%14.75M | -18.56%31.07M | -11.36%16.75M | 8.98%38.15M |
| -Amortization of intangible assets | -14.81%23K | -53.45%54K | -62.50%27K | -45.28%116K | -44.62%72K | -18.46%212K | -0.76%130K | -41.83%260K | -54.04%131K | -26.36%447K |
| Financial expense | 87.16%204K | -8.94%377K | -46.83%109K | -36.01%414K | -38.81%205K | -21.19%647K | -16.46%335K | -15.53%821K | -9.48%401K | 19.26%972K |
| Unrealized exchange loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 104.32%8K | ---- |
| Special items | 83.66%1.78M | -21.09%3.05M | -61.04%967K | -15.74%3.87M | 66.24%2.48M | 77.50%4.59M | -25.87%1.49M | -75.83%2.59M | -77.54%2.01M | -29.71%10.7M |
| Operating profit before the change of operating capital | 16.67%136.96M | 6.18%242.78M | 2.21%117.39M | 34.31%228.64M | 41.90%114.86M | 21.57%170.23M | 29.13%80.94M | 1,637.50%140.03M | 213.74%62.68M | -95.75%8.06M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -59.39%9.91M | 90.46%-1.11M | 40.14%24.41M | -2,150.00%-11.61M | 84.31%17.42M | -104.83%-516K | -71.24%9.45M | -51.34%10.67M | -8.41%32.86M | 163.36%21.94M |
| Accounts receivable (increase)decrease | -78.58%6.39M | 86.33%-4.57M | 59.50%29.81M | -59.99%-33.45M | 151.74%18.69M | -76.39%-20.91M | -222.39%-36.12M | -120.56%-11.85M | -57.51%29.51M | 620.89%57.64M |
| Accounts payable increase (decrease) | 132.94%11.5M | 443.39%32.21M | -20.48%-34.9M | -64.76%5.93M | -40.74%-28.97M | 152.05%16.82M | -6.27%-20.58M | 137.83%6.67M | 36.03%-19.37M | -85.43%-17.64M |
| prepayments (increase)decrease | -53.43%5.93M | 205.30%10.2M | 186.78%12.74M | -191.10%-9.69M | -227.02%-14.68M | 231.63%10.63M | -97.06%-4.49M | -135.96%-8.08M | -116.01%-2.28M | 327.91%22.47M |
| Special items for working capital changes | -216.54%-4.02M | 339.23%4.67M | 226.55%3.45M | 130.40%1.06M | -53.67%-2.72M | -221.85%-3.5M | 15.34%-1.77M | 45.10%2.87M | -391.50%-2.09M | 129.74%1.98M |
| Cash from business operations | 9.01%166.67M | 57.11%284.19M | 46.18%152.89M | 4.70%180.88M | 281.34%104.59M | 23.13%172.77M | -72.93%27.43M | 48.58%140.31M | 190.28%101.31M | -47.53%94.44M |
| Other taxs | -39.56%-23.16M | -268.35%-25.41M | -227.23%-16.59M | 35.98%-6.9M | -59.97%-5.07M | -6.81%-10.77M | 32.38%-3.17M | -15.41%-10.09M | 30.07%-4.69M | 20.08%-8.74M |
| Interest received - operating | 15.52%6.78M | 6.58%12.67M | 85.90%5.87M | 82.03%11.89M | 109.08%3.16M | 1,001.52%6.53M | 482.63%1.51M | -52.06%593K | -66.54%259K | -50.76%1.24M |
| Net cash from operations | 5.71%150.29M | 46.04%271.45M | 38.46%142.16M | 10.30%185.88M | 298.48%102.67M | 28.83%168.52M | -73.41%25.77M | 50.48%130.82M | 234.41%96.88M | -49.33%86.93M |
| Cash flow from investment activities | ||||||||||
| Decrease in deposits (increase) | 151.45%255.22M | -69.19%-171.73M | --101.5M | ---101.5M | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | -99.30%15K | -99.32%35K | 394.69%2.14M | 7,454.41%5.14M | --433K | -94.55%68K | ---- | 4,200.00%1.25M | --35K | 314.29%29K |
| Purchase of fixed assets | 12.07%-14.05M | 16.71%-24.63M | -62.67%-15.97M | -31.06%-29.58M | -6.14%-9.82M | 27.60%-22.57M | 57.11%-9.25M | 29.83%-31.17M | -2.04%-21.57M | 62.64%-44.42M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---228K | ---228K | ---- | ---- | ---- |
| Recovery of cash from investments | -25.78%825.32M | 44.49%1.89B | 159.44%1.11B | 175.31%1.31B | 37.20%428.64M | 70.56%476.12M | 143.52%312.41M | 82.22%279.16M | -2.44%128.29M | -25.17%153.2M |
| Cash on investment | 24.95%-833M | -45.41%-1.9B | -162.41%-1.11B | -176.69%-1.31B | -36.80%-423M | -87.82%-472M | -197.31%-309.2M | -46.70%-251.3M | 44.09%-104M | -31.77%-171.3M |
| Net cash from investment operations | 160.23%233.51M | -66.25%-201.38M | 2,491.58%89.73M | -550.84%-121.13M | 40.21%-3.75M | -799.52%-18.61M | -328.10%-6.28M | 96.69%-2.07M | 103.64%2.75M | -224.23%-62.5M |
| Net cash before financing | 65.50%383.79M | 8.23%70.08M | 134.42%231.89M | -56.81%64.75M | 407.52%98.92M | 16.44%149.91M | -80.44%19.49M | 426.83%128.75M | 313.48%99.64M | -83.95%24.44M |
| Cash flow from financing activities | ||||||||||
| Interest paid - financing | -87.16%-204K | 8.94%-377K | 46.83%-109K | 36.01%-414K | 38.81%-205K | 21.19%-647K | 16.46%-335K | 15.53%-821K | 9.48%-401K | -19.26%-972K |
| Dividends paid - financing | -13.25%-79.86M | ---70.52M | ---70.52M | ---- | ---- | ---- | ---- | ---35.02M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---17.8M | ---6.82M | ---- | ---- | ---- |
| Net cash from financing operations | -11.86%-82.65M | -976.68%-76.33M | -2,163.09%-73.89M | 71.72%-7.09M | 68.13%-3.27M | 39.70%-25.06M | -250.77%-10.25M | -437.35%-41.56M | 19.15%-2.92M | 96.22%-7.74M |
| Effect of rate | -578.47%-3.07M | -33.76%977K | -81.35%641K | -85.91%1.48M | -39.41%3.44M | 295.99%10.47M | 402.88%5.67M | 49.48%-5.34M | -148.80%-1.87M | -293.84%-10.58M |
| Other items affecting net cash | ---- | ---- | ---- | ---1K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net Cash | 90.59%301.14M | -110.84%-6.25M | 65.18%158M | -53.82%57.66M | 934.68%95.66M | 43.20%124.85M | -90.44%9.25M | 421.96%87.18M | 292.33%96.71M | 131.92%16.7M |
| Begining period cash | -0.63%835.2M | 7.57%840.47M | 7.57%840.47M | 20.95%781.34M | 20.95%781.34M | 14.51%646.02M | 14.51%646.02M | 1.10%564.18M | 1.10%564.18M | -7.75%558.05M |
| Cash at the end | 13.43%1.13B | -0.63%835.2M | 13.48%999.12M | 7.57%840.47M | 33.21%880.43M | 20.95%781.34M | 0.29%660.93M | 14.51%646.02M | 28.81%659.02M | 1.10%564.18M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | 13.43%1.13B | ---- | --999.12M | ---- | ---- | ---- | ---- | ---- | --659.02M | ---- |
| Cash and cash equivalent balance | 13.43%1.13B | ---- | --999.12M | ---- | ---- | ---- | ---- | ---- | --659.02M | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.